(Q37099006)

18 August 2017

1 reference

title

Therapeutic options for Acinetobacter baumannii infections (English)

1 reference

18 August 2017

Acinetobacter baumannii

1 reference

Jordi Vila

1

0 references

author name string

Jerónimo Pachón

series ordinal

2

1 reference

PubMed ID

18312160

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Expert Opinion on Pharmacotherapy

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

4

1 reference

18 August 2017

587-599

1 reference

AcinetobacterOutbreaks, 1977–2000

18 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Comparison of three standardized disc susceptibility testing methods for colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Transferable plasmid-mediated antibiotic resistance in Acinetobacter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Comparative genomics of multidrug resistance in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

The epidemiology and control of Acinetobacter baumannii in health care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Group B streptococcal soft tissue infections in non-pregnant adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Rapid development of Acinetobacter baumannii resistance to tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Successful treatment of Acinetobacter meningitis with meropenem and rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Colonization or Infection with Multidrug-Resistant Acinetobacter baumannii May Be an Independent Risk Factor for Increased Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Prevalencia de los genes tetA y tetB como mecanismo de resistencia a tetraciclina y minociclina en aislamientos clínicos de Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Outbreak of Infection With Acinetobacter Strain RUH 1139 in an Intensive Care Unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

Prevalence of ISAba1in epidemiologically unrelatedAcinetobacter baumanniiclinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.587

21 January 2018

Identifiers

DOI

10.1517/14656566.9.4.587

1 reference

release_ch27anb3m5drlco6hscm4nihny

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ch27anb3m5drlco6hscm4nihny

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18312160

1 reference

PubMed ID

18312160